SMYD2 and cervical cancer: SMYD2 also alters the methylation status of p53 and inhibits its transcriptional activity; SMYD2 knockdown induces a metabolic shift from aerobic glycolysis to oxidative phosphorylation, while SMYD2 overexpression promotes glycolytic metabolism in cervical cancer cells [72].